19 results for author:"Milburn M.V." in Literature citations
Results Customize
› Repeat search in UniProtKB (14)
| Detrimental effects of adenosine signaling in sickle cell disease. Zhang Y., Dai Y., Wen J., Zhang W., Grenz A., Sun H., Tao L., Lu G., Alexander D.C., Milburn M.V. et al. Nat. Med. 17:79-86(2011) · Mapped (14) |
| Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Artis D.R., Lin J.J., Zhang C., Wang W., Mehra U., Perreault M., Erbe D., Krupka H.I., England B.P., Arnold J. et al. Proc. Natl. Acad. Sci. U.S.A. 106:262-267(2009) · UniProtKB (2) · Mapped (2) |
| The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Wang W., Zhang C., Marimuthu A., Krupka H.I., Tabrizizad M., Shelloe R., Mehra U., Eng K., Nguyen H., Settachatgul C. et al. Proc. Natl. Acad. Sci. U.S.A. 102:7505-7510(2005) · UniProtKB (2) · Mapped (1) |
| A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design. Card G.L., Blasdel L., England B.P., Zhang C., Suzuki Y., Gillette S., Fong D., Ibrahim P.N., Artis D.R., Bollag G. et al. Nat. Biotechnol. 23:201-207(2005) · UniProtKB (2) |
| Structural basis for the activity of drugs that inhibit phosphodiesterases. Card G.L., England B.P., Suzuki Y., Fong D., Powell B., Lee B., Luu C., Tabrizizad M., Gillette S., Ibrahim P.N. et al. |
| A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases. Zhang K.Y.J., Card G.L., Suzuki Y., Artis D.R., Fong D., Gillette S., Hsieh D., Neiman J., West B.L., Zhang C. et al. |
| Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Gampe R.T. Jr., Montana V.G., Lambert M.H., Wisely G.B., Milburn M.V., Xu H.E. Genes Dev. 14:2229-2241(2000) · UniProtKB (1) |
| Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Gampe R.T. Jr., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., Xu H.E. |
| Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. Xu R.X., Hassell A.M., Vanderwall D., Lambert M.H., Holmes W.D., Luther M.A., Rocque W.J., Milburn M.V., Zhao Y., Ke H. et al. Science 288:1822-1825(2000) · UniProtKB (1) |
| Anatomy of a proficient enzyme: the structure of orotidine 5'-monophosphate decarboxylase in the presence and absence of a potential transition state analog. Miller B.G., Hassell A.M., Wolfenden R., Milburn M.V., Short S.A. Proc. Natl. Acad. Sci. U.S.A. 97:2011-2016(2000) · UniProtKB (1) |
| A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Oberfield J.L., Collins J.L., Holmes C.P., Goreham D.M., Cooper J.P., Cobb J.E., Lenhard J.M., Hull-Ryde E.A., Mohr C.P., Blanchard S.G. et al. Proc. Natl. Acad. Sci. U.S.A. 96:6102-6106(1999) · Mapped (1) |
| Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Xu H.E., Lambert M.H., Montana V.G., Parks D.J., Blanchard S.G., Brown P.J., Sternbach D.D., Lehmann J.M., Wisely G.B., Willson T.M. et al. Mol. Cell 3:397-403(1999) · UniProtKB (1) |
| Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. McInerney E.M., Rose D.W., Flynn S.E., Westin S., Mullen T.M., Krones A., Inostroza J., Torchia J., Nolte R.T., Assa-Munt N. et al. Genes Dev. 12:3357-3368(1998) · Mapped (1) |
| Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V. Nature 395:137-143(1998) · UniProtKB (2) |
| A novel dimer configuration revealed by the crystal structure at 2.4-A resolution of human interleukin-5. Milburn M.V., Hassell A.M., Lambert M.H., Jordan S.R., Proudfoot A.E.I., Graber P., Wells T.N.C. Nature 363:172-176(1993) · UniProtKB (1) |
| Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. de Vos A.M., Tong L., Milburn M.V., Matias P.M., Jancarik J., Noguchi S., Nishimura S., Miura K., Ohtsuka E., Kim S.-H. Science 239:888-893(1988) · UniProtKB (1) |
| Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Milburn M.V., Tong L., deVos A.M., Brunger A., Yamaizumi Z., Nishimura S., Kim S.H. Science 247:939-945(1990) · Mapped (1) |
| Crystal structures at 2.2-A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP. Tong L.A., de Vos A.M., Milburn M.V., Kim S.H. J. Mol. Biol. 217:503-516(1991) · UniProtKB (1) |
| Three-dimensional structures of the ligand-binding domain of the bacterial aspartate receptor with and without a ligand. Milburn M.V., Prive G.G., Milligan D.L., Scott W.G., Yeh J., Jancarik J., Koshland D.E. Jr., Kim S.-H. Science 254:1342-1347(1991) · UniProtKB (1) |